Press Release

EVERSANA™, integrated commercial services platform for the global life sciences industry, announced its acquisition of Intouch Group®, a full-service global agency network serving the pharmaceutical industry. The acquisition cements EVERSANA’s position as a $1 billion commercial services leader with with a bigger workforce and expanded presence poised to solve broad range of challenges that include pricing, access, reimbursement, promotion, adherence, or product delivery challenge.

“Today marks a milestone day for not only our employees and clients, but for an industry desperately in need of a better way to bring innovations to market, create long-term value, and improve patient lives. with the added power of Intouch and millions more invested in data, analytics and digital transformation, we are reinventing commercial approaches for the benefit of our clients and their patients.”

JIM LANG, CEO OF EVERSANA.

“This is so much more than an integration. This is our opportunity to improve every sector of product commercialization. Over the last 20 years we transformed pharmaceutical promotion and digital engagement. Imagine what the next 20 years will bring as we set our sights even higher, unafraid to transform health care as we know it.”

Faruk Capan, CEO of Intouch Group.

Basis the agreement, Agencies from both firms will integrate, as EVERSANA ENGAGE joins forces with the Intouch agency network. Faruk Capan will now reports to Jim Lang.